BIOMAT Database Logo BIOMAT Database Logo

Telomere shortening in human HL60 cells by treatment with 3'-azido-2',3'-dideoxynucleosides and telomerase inhibition by their 5'-triphosphates. 2007

Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
Biotechnology Research Center, Teikyo University of Science and Technology, Uenohara, Yamanashi, Japan.

Telomerase is thought to play an important role in the mechanism of tumor cell immortalization by maintenance of telomere length. To obtain information on the susceptibility of telomerase to nucleoside analogues, the effects of base-modified 3'-azido-2',3'-dideoxynucleoside triphosphates on the enzyme were investigated. It is suggested that the 2-amino group of the nucleotide purine nucleus is important for the inhibitory activity. Telomere shortening caused by long-term treatment with these nucleosides is also described.

UI MeSH Term Description Entries
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D016048 Dideoxyadenosine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by a hydrogen. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is an inhibitor of HIV replication, acting as a chain-terminator of viral DNA by binding to reverse transcriptase. Its principal side effect is nephrotoxicity. In vivo, dideoxyadenosine is rapidly metabolized to DIDANOSINE (ddI) by enzymatic deamination; ddI is then converted to dideoxyinosine monophosphate and ultimately to dideoxyadenosine triphosphate, the putative active metabolite. 2',3'-Dideoxyadenosine,ddA (Antiviral),2',3' Dideoxyadenosine
D016615 Telomere A terminal section of a chromosome which has a specialized structure and which is involved in chromosomal replication and stability. Its length is believed to be a few hundred base pairs. Telomeres
D054306 Dideoxynucleotides The phosphate esters of DIDEOXYNUCLEOSIDES. Dideoxynucleotide Triphosphates,ddNTPs,Triphosphates, Dideoxynucleotide
D018922 HL-60 Cells A promyelocytic cell line derived from a patient with ACUTE PROMYELOCYTIC LEUKEMIA. HL-60 cells lack specific markers for LYMPHOID CELLS but express surface receptors for FC FRAGMENTS and COMPLEMENT SYSTEM PROTEINS. They also exhibit phagocytic activity and responsiveness to chemotactic stimuli. (From Hay et al., American Type Culture Collection, 7th ed, pp127-8) HL60 Cells,Cell, HL60,Cells, HL60,HL 60 Cells,HL-60 Cell,HL60 Cell
D019098 Telomerase An essential ribonucleoprotein reverse transcriptase that adds telomeric DNA to the ends of eukaryotic CHROMOSOMES. Telomerase Catalytic Subunit,Telomerase Reverse Transcriptase,Telomerase Reverse Transcriptase Catalytic Subunit,Catalytic Subunit, Telomerase,Reverse Transcriptase, Telomerase,Subunit, Telomerase Catalytic,Transcriptase, Telomerase Reverse

Related Publications

Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.
January 2007, Nucleic acids research,
Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
Telomere shortening in human HL60 cells by treatment with deoxyguanosine analogs.
January 2004, Nucleic acids symposium series (2004),
Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
Irreversible telomere shortening by 3'-azido-2',3'-dideoxythymidine (AZT) treatment.
May 1998, Biochemical and biophysical research communications,
Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
The 5'-triphosphates of 3'-azido-3'-deoxythymidine and 2', 3'-dideoxynucleosides inhibit DNA polymerase gamma by different mechanisms.
September 1991, Biochemical and biophysical research communications,
Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
Influence of 3'-azido-2',3'-dideoxyguanosine treatment on telomere length in human telomerase-immortalized human fibroblast cells.
January 2009, Nucleic acids symposium series (2004),
Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
[Inhibition of HIV reproduction in cell culture by 5'-phosphonates of 3'-azido-2',3'-dideoxynucleosides].
January 1989, Molekuliarnaia biologiia,
Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
[Suppression of the human immunodeficiency virus in cultured cells by 5'-phosphites of 3'-azido-2',3'-dideoxynucleosides].
January 1990, Molekuliarnaia biologiia,
Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
Inhibition of human telomerase by L-enantiomers of natural 2'-deoxyribonucleoside 5'-triphosphates.
January 2001, Nucleosides, nucleotides & nucleic acids,
Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.
August 1998, Biochemical and biophysical research communications,
Xiaohong Liu, and Motoko Inomata, and Tsukasa Ogawara, and Mineo Saneyoshi, and Toyofumi Yamaguchi
Inhibition of tankyrase 1 in human gastric cancer cells enhances telomere shortening by telomerase inhibitors.
October 2010, Oncology reports,
Copied contents to your clipboard!